Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes

Posted in Autoimmune diabetes  at Sun, 02 Nov 2008 00:36:39 -0700

CONCLUSIONS—Targeting CD22 depletes and reprograms B-cells and reverses autoimmune diabetes, thereby providing a blueprint for development of novel therapies to cure autoimmune diabetes.

Original article: Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes by at autoimmune diabetes - Google Blog Search

Tags: